Kinsale Capital Group, Inc.
KNSL
$349.10
+5.06%
Kinsale Capital Group is a specialty insurance holding company focused on the excess and surplus (E&S) lines market, offering property, casualty, and specialty insurance products to niche sectors such as allied health, healthcare, life sciences, and public entities. As a leading player in the E&S market, Kinsale distinguishes itself through disciplined underwriting, technology-driven efficiency, and a consistent track record of profitable growth, positioning it as a high-quality operator in a fragmented and often volatile segment of the insurance industry. The current investor narrative centers on the company's ability to sustain its growth trajectory amid a softening pricing cycle in E&S lines, with attention on margin resilience and the impact of competitive pressures on premium growth. Recent quarterly results showed revenue growth of 10.2% year-over-year, but the stock has declined nearly 29% over the past year, reflecting concerns about decelerating growth and potential margin compression.…
KNSL
Kinsale Capital Group, Inc.
$349.10
Investment Opinion: Should I buy KNSL Today?
Rating: Hold. Thesis: Kinsale is a high-quality insurer with strong margins and low valuation, but decelerating growth and negative momentum warrant a cautious stance. The analyst consensus is 'hold' with an average target of $346.00, implying limited upside. Supporting Evidence: The trailing P/E of 17.97x is an 18% discount to the industry average of 22.0x, and the PEG ratio of 0.84x suggests undervaluation. Revenue growth of 10.2% YoY is still positive but decelerating. Net margin of 24.1% and ROE of 25.7% are exceptional. Free cash flow of $1.01 billion TTM provides a strong financial cushion. Risks & Conditions: The biggest risks are further growth deceleration and margin compression. This Hold would upgrade to Buy if revenue growth re-accelerates above 15% or the P/E compresses below 15x. It would downgrade to Sell if growth falls below 5% or net margin drops below 20%. Valuation verdict: The stock appears undervalued relative to its historical P/E range and PEG ratio, but the market is pricing in the growth deceleration, making it fairly valued at current levels.
Sign up to view all
KNSL 12-Month Price Forecast
Kinsale's investment case is finely balanced. The stock's low valuation (PEG 0.84x) and strong profitability (ROE 25.7%) provide a floor, but the decelerating growth and negative price momentum (28.9% annual decline) cap upside. The base case of modest growth and stable margins supports a hold rating with limited near-term upside. A bullish stance would require evidence of growth re-acceleration, such as a quarterly revenue beat above 12% YoY. A bearish stance would be triggered if growth falls below 5% or margins compress significantly. The neutral stance reflects the lack of a clear catalyst to break the current range.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Kinsale Capital Group, Inc.'s 12-month outlook, with a consensus price target around $347.11 and implied upside of -0.6% versus the current price.
Average Target
$347.11
0 analysts
Implied Upside
-0.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$267 - $405
Analyst target range
Kinsale is covered by 9 analysts, with a consensus recommendation of 'hold' (mean rating 3.17 on a 1-5 scale where 1 is strong buy). The average target price is $346.00, implying a modest 0.6% upside from the current price of $343.99. The distribution shows 2 buys, 5 holds, and 2 sells, reflecting a cautious stance. The implied upside to the average target is minimal, suggesting that analysts see limited near-term upside. The target price range spans from a low of $267.00 to a high of $405.00, a spread of $138 (52% of the average target), indicating significant uncertainty about the stock's future. The high target of $405.00 assumes a recovery in growth and margin expansion, while the low target of $267.00 prices in further deterioration in the E&S market or underperformance. Recent rating actions include downgrades from Wells Fargo (Overweight to Equal Weight in April 2026) and Morgan Stanley (Overweight to Equal Weight in April 2026), as well as a downgrade from Jefferies (Hold to Underperform in March 2026). These downgrades reflect growing caution among analysts, aligning with the stock's downtrend and the deceleration in growth.
Bulls vs Bears: KNSL Investment Factors
Kinsale Capital presents a mixed picture: strong profitability, low leverage, and a historically low P/E ratio argue for value, while decelerating growth, negative price momentum, and cautious analyst sentiment argue caution. The bull case rests on the stock's cheap valuation (PEG 0.84x) and high ROE (25.7%) suggesting a potential turnaround if growth stabilizes. The bear case centers on the growth deceleration (10.2% YoY) and the stock's 28.9% annual decline, which may continue if the E&S market softens. The single most important tension is whether the growth deceleration is cyclical and temporary or structural and permanent. If growth re-accelerates, the stock could re-rate higher; if it continues to slow, further downside is likely.
Bullish
- Strong Profitability and Margins: Kinsale's net margin of 24.1% and operating margin of 29.9% in Q1 2026 are well above industry averages for property & casualty insurers, demonstrating disciplined underwriting and expense management. Gross margin improved to 39.9% from 36.5% a year earlier, indicating pricing power and cost control.
- Low Valuation Relative to History: The trailing P/E of 17.97x is near the low end of its five-year range of 16.3x to 48.2x, suggesting the stock is pricing in trough earnings expectations. The PEG ratio of 0.84x implies undervaluation relative to earnings growth, offering a potential margin of safety.
- Exceptional Return on Equity: ROE of 25.7% is exceptional, reflecting Kinsale's ability to generate high returns on shareholder capital. This is a key metric for insurance companies and indicates efficient capital allocation and competitive advantage.
- Strong Free Cash Flow Generation: Trailing twelve-month free cash flow of $1.01 billion provides ample liquidity for growth investments and capital returns. Free cash flow in Q1 2026 was $241.3 million, up from $217.6 million a year earlier, supporting financial flexibility.
Bearish
- Decelerating Revenue Growth: Revenue growth slowed to 10.2% YoY in Q1 2026 from 18.4% in Q2 2025 and 21.2% in Q4 2024, indicating a clear deceleration. This trend raises concerns about competitive pressures and a softening pricing cycle in the E&S market.
- Significant Stock Underperformance: The stock has declined 28.9% over the past year, vastly underperforming the S&P 500's 18.4% gain. The maximum drawdown of 40.8% highlights severe downside volatility and negative investor sentiment.
- Cautious Analyst Consensus: With a consensus rating of 'hold' and an average target price of $346.00 (only 0.6% upside), analysts see limited near-term upside. Recent downgrades from Wells Fargo and Morgan Stanley reflect growing caution.
- Potential Margin Compression Ahead: While margins are strong, the deceleration in revenue growth may lead to margin pressure if pricing softens further. The Q1 2026 net margin of 24.1% is down from 28.7% in Q4 2025, suggesting some compression is already occurring.
KNSL Technical Analysis
Kinsale Capital is in a sustained downtrend, with the stock price declining 28.9% over the past year, significantly underperforming the S&P 500's 18.4% gain. The current price of $343.99 sits at 67% of its 52-week range (low $287.20, high $512.76), indicating it is closer to the low end of the range. This positioning suggests the stock is in a bearish phase, with the price having lost substantial ground from its highs, potentially offering a value opportunity if fundamentals stabilize, but also carrying the risk of further downside if negative momentum persists. The 1-month price change of +11.2% shows a short-term bounce, while the 3-month change of -4.7% and 6-month change of -13.8% highlight the broader downtrend. This divergence—a positive 1-month return within a negative longer-term trend—could signal a temporary relief rally or the early stages of a trend reversal, but the 3-month and 6-month declines suggest that selling pressure remains dominant. The stock's beta of 0.90 indicates slightly lower volatility than the market, but the recent price action has been more volatile than the beta suggests, with a maximum drawdown of 40.8% over the period. The 52-week high of $512.76 represents a key resistance level, while the 52-week low of $287.20 serves as support. A breakout above $512.76 would signal a potential trend reversal, while a breakdown below $287.20 could indicate further downside. The stock's beta of 0.90 implies it is less volatile than the market, but the recent drawdown and sharp moves suggest that risk management is critical, especially given the stock's underperformance relative to the S&P 500 over the past year.
Beta
—
—
Max Drawdown
-40.8%
Largest decline past year
52-Week Range
$287-$513
Price range past year
Annual Return
-26.7%
Cumulative gain past year
| Period | KNSL Return | S&P 500 |
|---|---|---|
| 1m | +12.5% | +0.8% |
| 3m | +1.2% | +3.5% |
| 6m | -14.2% | +7.2% |
| 1y | -26.7% | +16.5% |
| ytd | -11.0% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
KNSL Fundamental Analysis
Kinsale's revenue has grown consistently, with the most recent quarterly revenue of $466.7 million in Q1 2026 representing a 10.2% year-over-year increase. However, growth has decelerated from the 18.4% YoY growth seen in Q2 2025 and the 21.2% growth in Q4 2024, indicating a slowdown in premium expansion. The company's revenue trajectory remains positive but is moderating, which is a key concern for investors as the E&S market faces increased competition and potential pricing headwinds. The company is highly profitable, with net income of $112.6 million in Q1 2026 and a net margin of 24.1%. Gross margin improved to 39.9% in Q1 2026 from 36.5% in Q1 2025, while operating margin expanded to 29.9% from 26.5% over the same period, reflecting strong underwriting discipline and expense management. These margins are well above industry averages for property & casualty insurers, underscoring Kinsale's competitive advantage in underwriting and claims management. Kinsale maintains a strong balance sheet with a debt-to-equity ratio of 0.11, indicating low leverage. Free cash flow was $241.3 million in Q1 2026, up from $217.6 million in Q1 2025, and the trailing twelve-month free cash flow of $1.01 billion provides ample liquidity for growth and capital returns. Return on equity (ROE) of 25.7% is exceptional, reflecting the company's ability to generate high returns on shareholder capital. The current ratio of 0.84 suggests adequate short-term liquidity, though the company operates with a float-based model typical of insurers.
Quarterly Revenue
$466709000.0B
2026-03
Revenue YoY Growth
+10.2%
YoY Comparison
Gross Margin
39.9%
Latest Quarter
Free Cash Flow
$1.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is KNSL Overvalued?
Given that net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 17.97x, while the forward P/E is 15.87x, implying that the market expects earnings growth over the next year. The gap between trailing and forward P/E suggests a modest growth premium, consistent with the company's historical growth trajectory. Compared to the industry average P/E of 22.0x (estimated), Kinsale's trailing P/E of 17.97x represents a discount of approximately 18%. This discount may be justified by the decelerating growth rate and concerns about the pricing cycle, but it also reflects the market's cautious stance. The P/B ratio of 4.62x is above the industry average of 1.5x, indicating a premium on book value due to the company's high ROE and intangible assets. Historically, Kinsale's trailing P/E has ranged from 16.3x to 48.2x over the past five years, with the current 17.97x near the low end of that range. This suggests that the stock is trading at a valuation that has historically been associated with trough earnings expectations, potentially offering a margin of safety if the company can maintain its profitability. The PEG ratio of 0.84x indicates that the stock is undervalued relative to its earnings growth rate, supporting the case for a value opportunity.
PE
18.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 16x~44x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Kinsale's primary financial risk is the deceleration in revenue growth, which fell to 10.2% YoY in Q1 2026 from over 20% in prior quarters. This could pressure margins if competitive pricing forces lower premiums. The company's debt-to-equity ratio is low at 0.11, so balance sheet risk is minimal, but the high ROE of 25.7% may be unsustainable if underwriting margins compress. Free cash flow remains strong at $1.01 billion TTM, but a prolonged growth slowdown could reduce cash generation and limit capital returns. Market & Competitive Risks: The stock's beta of 0.90 suggests lower market correlation, but the 28.9% annual decline shows it is highly sensitive to sector-specific headwinds. The E&S market faces a softening pricing cycle, and increased competition could pressure premium growth. The stock's P/B of 4.62x is well above the industry average of 1.5x, exposing it to multiple compression if ROE declines. Recent analyst downgrades (Wells Fargo, Morgan Stanley) highlight growing skepticism. Worst-Case Scenario: In a severe downturn where growth stalls and margins compress, the stock could fall to its 52-week low of $287.20, representing a 16.5% decline from the current price of $343.99. If the E&S market enters a hard cycle with widespread price cuts, the low analyst target of $267.00 implies a 22.4% downside. The maximum historical drawdown of 40.8% suggests that in a worst-case scenario, losses could exceed 40% from current levels.
FAQ
The key risks are: 1) Growth deceleration: Revenue growth slowed to 10.2% YoY in Q1 2026 from over 20% in prior quarters, and further deceleration could pressure the stock. 2) Margin compression: Net margin of 24.1% is strong but down from 28.7% in Q4 2025, and a continued decline would hurt profitability. 3) Competitive pressure: The E&S market is fragmented and competitive; a softening pricing cycle could reduce premium growth and underwriting margins. 4) Negative momentum: The stock is down 28.9% over the past year and has a maximum drawdown of 40.8%, indicating high downside volatility. The most severe risk is a prolonged soft market that pushes the stock to the analyst low target of $267.00, a 22.4% decline from current levels.
The 12-month forecast for KNSL is mixed, with three scenarios: Bull case (20% probability) sees the stock reaching $380-$405 if growth re-accelerates to 15%+ YoY and the P/E expands to 20x. Base case (55% probability) expects the stock to trade in a $320-$360 range, near the analyst average target of $346.00, as growth stabilizes at 8-10% and margins hold. Bear case (25% probability) sees the stock falling to $267-$300 if growth slows below 5% and margins compress, driven by a soft E&S market. The most likely scenario is the base case, assuming continued deceleration but no major deterioration. The AI assessment is neutral with medium confidence, reflecting the balanced risk/reward.
Based on historical and peer comparisons, KNSL appears undervalued. The trailing P/E of 17.97x is near the low end of its five-year range of 16.3x to 48.2x, and the PEG ratio of 0.84x indicates the stock is cheap relative to its earnings growth rate. Compared to the industry average P/E of 22.0x, KNSL trades at an 18% discount. However, the P/B ratio of 4.62x is well above the industry average of 1.5x, reflecting the company's high ROE and intangible assets. The market is pricing in the growth deceleration, which justifies the discount to historical multiples. Overall, the stock is undervalued on an earnings basis but fairly valued when considering the growth slowdown.
KNSL is a good buy for investors seeking a high-quality insurer at a discounted valuation, but only if they have a medium-to-long-term horizon and can tolerate continued volatility. The stock's trailing P/E of 17.97x is an 18% discount to the industry average of 22.0x, and the PEG ratio of 0.84x suggests undervaluation relative to earnings growth. However, the decelerating revenue growth (10.2% YoY) and negative price momentum (down 28.9% over the past year) pose near-term risks. The analyst consensus is 'hold' with an average target of $346.00, implying only 0.6% upside. For value investors willing to bet on a growth re-acceleration, the current price offers a favorable risk/reward. For momentum-oriented investors, the stock is not a good buy until the downtrend reverses.
KNSL is more suitable for long-term investment due to its strong fundamentals and discounted valuation, but it carries near-term uncertainty. The stock's beta of 0.90 indicates lower volatility than the market, but the 28.9% annual decline and 40.8% maximum drawdown show it can be volatile. The dividend yield is negligible at 0.17%, so income-seeking investors should look elsewhere. For long-term investors (3-5 years), the low P/E and high ROE (25.7%) provide a compelling entry point if the company can sustain its competitive advantages. Short-term traders may find the stock range-bound with limited upside catalysts. A minimum holding period of 12-18 months is recommended to allow for a potential growth re-acceleration or valuation re-rating.